Natco Pharma Shares Rally 9% Despite Weak Q2 Results; Details Inside

Revenue from operations or top line declined 29% YoY to Rs 967 crore in Q2FY27, from Rs 1,363 crore in the year-ago period.
Read the full story on NDTV Profit Opens ndtvprofit.com in a new tab
Advertisement
Tech RajeshwarNeed a new website?Websites & apps built for your business — contact Tech RajeshwarContact us
This is a short summary of a story published by NDTV Profit, shown with a link to the original. The full story, photo and reporting belong to NDTV Profit.












